Holmes BioPharma is Selected as a Preferred Service Provider by a Major Pharmaceutical Company

SCOTTSDALE, ARIZONA--(MARKET WIRE)--Jul 19, 2007 -- Holmes Biopharma, Inc. (Other OTC:HLMB.PK - News) is pleased to announce, a major pharmaceutical company known for "continuous outsourcing of Phase I clinical studies valued at $26 million annually", has selected Qualia Clinical Services as one of four preferred service providers.

Back to news